Medicine


Showing 751-800 of 1,152 Results

  • Dale Gene O'Brien

    Dale Gene O'Brien

    Adjunct Clinical Assistant Professor, Medicine - Oncology

    BioDale O’Brien, MD, MPH is adjunct faculty at the Stanford University School of Medicine in the Oncology Division. He founded several medical clinics for vulnerable populations in under-resourced areas of northern California where he has been a practicing physician for more than four decades.

    A graduate of the University of Missouri School of Medicine, he took postgraduate training at the Oregon Health & Science University, and the University of California (San Francisco) / University of California School of Public Health. He is board certified by the American Board of Family Medicine and by the American Board of Preventive Medicine.

    Dr. O'Brien treated hippies at the White Bird Clinic in Eugene, Oregon in the mid-70s; served as the acting Health Officer of the Shasta County Health Department in California; and spent two years in the early 80s as an affiliate of the European Branch Headquarters of the World Health Organization in Denmark.

    As the Executive Director of the nonprofit Cancer Patients Alliance (CPA) since 2001, Dr. O’Brien and his team have advocated for and supported low-income Latino community members, immigrants and farm workers with cancer in the Salinas Valley agricultural region of Monterey County, California.

    Dr. O’Brien was Co-Principal Investigator of the Stanford Cancer Institute's Developmental Research Award in Translational Science, "Building an Academic-Community Partnership to Understand and Address Barriers to Cancer Care in the Salinas Valley Region of Monterey County," 2010 – 2015.

    CPA has trained a number of Stanford University medical and post-doctoral students on behalf of the Valley Fellowship Program beginning in 2010 until the present.

    Dr. O'Brien was a member of the Stanford / Medable team that developed the cancer aftercare app called TOGETHERCare - per NIH / NCI (SBIR 363) Phase 1 and 2 grants from 9/18/2017 until 9/30/2022.

    Dr. O’Brien was on the Stanford-based research team in 2018 that piloted and studied the efficacy of the “Healthkey” behavioral health app for SAMHSA, CDC and the Council of State and Territorial Epidemiologists.

    Beginning 2019, he was Co-Principal Investigator with the Stanford University group that has helped reduce cancer disparities by increasing access to the emerging DNA technologies - and facilitating cultural translation in Monterey County - pursuant to 4-year support from the California Initiative to Advance Precision Medicine.

    In 2021, CPA received a 5-year grant award from the Robert Wood Johnson Foundation to further their advocacy work with the Latino community and farm workers with cancer in the Salinas Valley.

    In June 2021, CPA was selected by the California GOTV medical academic consortium including the Stanford University School of Medicine as led by UCLA - to conduct the "Get Out the Vaccine to Stop Covid-19" initiative for low-income populations in Monterey County, California.

    Dr. O'Brien was awarded a grant from SAMHSA through the California Department of Health Care Services (administered by Sierra Health Foundation) as the Lead for the 2024-2025 collaborative consisting of CPA, Monterey County Behavioral Health, Mujeres en Acción, and NAMI Monterey County for the "Behavioral Health Recovery, Access and Equity for Latinos" (BHRAEL) initiative.

    Since 2016 Dr. O'Brien has been on the Institutional Review Board of Clinica de Salud del Valle de Salinas. He is currently a member of the Stanford Cancer Institute Community Advisory Board. Dr. O’Brien is a past editor of the Berkeley Wellness Letter, Medicine on the Net and Cancer Informatics.

  • John Openshaw

    John Openshaw

    Assistant Professor of Medicine (Infectious Diseases and Geographic Medicine)

    Current Research and Scholarly InterestsMy research laboratory addresses questions at the intersection of infectious diseases and environmental change. We use field, laboratory, and computational approaches and our work ranges from basic epidemiologic and risk-factor studies to serologic surveys to developing new data collection tools and pathways.

  • Lars Osterberg, MD, MPH

    Lars Osterberg, MD, MPH

    Lecturer, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsBarriers to Humanism

    Collaborative Faculty Development in Improving Humanism and Professionalism

    Using Radiofrequency Identificaton technology to improve medication adherence

    Impact of Learning Communities on Medical Education

  • Linda K. Ottoboni, PhD, CNS

    Linda K. Ottoboni, PhD, CNS

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsLearning more about the patient lived experiences with cardiac arrhythmias and their perceived resources believed to provide support to achieve Quality of Life.

  • Natalie Pageler

    Natalie Pageler

    Clinical Professor, Clinical Informatics
    Clinical Professor, Medicine - Biomedical Informatics Research

    Current Research and Scholarly InterestsIn my administrative role, I oversee the development and maintenance of clinical decision support tools within the electronic medical record. These clinical decision support tools are designed to enhance patient safety, efficiency, and quality of care. My research focuses on rigorously evaluating--1) how these tools affect clinician knowledge, attitudes, and behaviors; and 2) how these tools affect clinical outcomes and efficiency of health care delivery.

  • Neda Pakdaman

    Neda Pakdaman

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Pakdaman practices Internal Medicine in Silicon Valley. She received her medical education at Yale University School of Medicine where she earned the Janet M. Glasgow Memorial Achievement Award for Women in Medicine. She completed her residency in Internal Medicine at Stanford University Hospital and was nominated for the Alwin Rambar-James Mark Award for Excellence in Patient Care.

    Dr. Pakdaman has been involved in developing innovative models for patient centered practice delivery. She has extensive background in Concierge Medicine as well as Executive Medicine. In addition, prior to coming to Stanford, she helped initiate and served as medical director for the Palliative Care inpatient consult service at El Camino Hospital. During that time, she served as chair of the El Camino Hospital Ethics Committee and as an advisory member for the Genomics Medicine Institute at El Camino Hospital. Drawing from her experiences working in both executive health programs and retainer based practices, she joined Stanford in 2012 to help launch Stanford Concierge Medicine. She subsequently served as the Medical Director of Stanford Concierge Medicine and Stanford Executive Health for five years where she helped pilot aspects of Stanford Precision Health platform.

    Dr. Pakdaman's clinical focus is adult primary care with health promotion and disease prevention/management.

    Board Certified Internal Medicine 2003, 2013
    Board Certified Hospice and Palliative Medicine 2008, 2018

  • Latha Palaniappan, MD, MS

    Latha Palaniappan, MD, MS

    Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health

    Current Research and Scholarly InterestsDr. Palaniappan has published over 200 peer reviewed manuscripts, abstracts, and book chapters over the last 20 years in the areas of chronic disease prevention and treatment in diverse populations. She has expertise in epidemiological research using big data, use of electronic health records for research, and clinical trials.

  • Minggui Pan, MD, PhD

    Minggui Pan, MD, PhD

    Clinical Professor, Medicine - Oncology

    BioDr. Pan is a board-certified, fellowship-trained medical oncologist with the Stanford Medicine Cancer Center and a clinical professor in the Department of Medicine, Division of Oncology.

    He diagnoses and treats various oncological conditions and specializes in the treatment of bone and soft tissue sarcoma. He creates personalized and comprehensive care plans for each patient he serves.

    Dr. Pan’s research focuses include understanding how genomic alterations impact the biological behavior and prognosis of sarcomas. In his work, he identifies new targets for developing innovative therapeutics for sarcoma treatment.

    Dr. Pan has more than eighty publications and presented many abstracts in several cancer and immunology conferences. His papers have been published in the Journal of Clinical Oncology, JCO Precision Oncology, Clinical Cancer Research, Nature Review Clinical Oncology, Nature Nanotechnology, Frontier Endocrinology, JCO Oncology Practice, Journal of Hematology and Oncology, British Journal of Cancer Reports, and other peer-reviewed journals. He has also presented to his peers at international, national, and regional meetings, including the annual meetings of American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), European Society for Medical Oncology (ESMO), Chinese Society Of Clinical Oncology (CSCO), Connective Tissue Oncology Society (CTOS) and others.

    Dr. Pan is a member of American Society of Clinical Oncology, American Association for Cancer Research, American Association of Immunologists, American Association for Advancement of Science, Society for Immunotherapy of Cancer, and Connective Tissue Oncology Society. Dr. Pan is also an adjunct investigator with Kaiser Permanente Division of Research.

  • Alan C. Pao

    Alan C. Pao

    Associate Professor of Medicine (Nephrology) and, by courtesy, of Urology

    Current Research and Scholarly InterestsWe are broadly interested in how the kidneys control salt, water, and electrolyte homeostasis in the body. Our disease focus is on kidney stone disease. We use cultured kidney cells, transgenic mice, human plasma/urine samples, and electronic health record data to study the pathogenesis of kidney stone disease. Our therapeutic focus is on the development of small molecule compounds that can be used for kidney stone prevention.

  • Divya Parikh, MD

    Divya Parikh, MD

    Clinical Assistant Professor, Medicine - Oncology

    BioDr. Divya Parikh is board-certified in both medical oncology and internal medicine. She obtained her medical degree from Boston University School of Medicine and completed both her residency and fellowship through Stanford University. During her fellowship, she simultaneously earned a Master of Science in health policy from Stanford University.

    Dr. Parikh specializes in the care of patients with genitourinary cancers. In addition to her clinical responsibilities, she currently is a clinical assistant professor of medical oncology at Stanford School of Medicine. She mentors medical residents and fellows by sharing her insights, knowledge, and expertise.

    Dr. Parikh has a strong research background. She has published in multiple academic journals and presented her findings through poster and oral presentations at various medical conferences.

  • Victoria Parikh, MD

    Victoria Parikh, MD

    Associate Professor of Medicine (Cardiovascular Medicine)

    BioDr. Parikh is a clinician scientist who cares for patients with and studies inherited (genetic) cardiovascular disease. She is the director of the Stanford Center for Inherited Cardiovascular Disease (SCICD) which is one of the largest of its kind in the country. SCICD integrates clinical and basic science with the expert care of patients with genetic cardiovascular conditions (e.g., cardiomyopathies, arrhythmias and vascular diseases). It provides cutting edge care for thousands of patients and families across the lifespan and integrates medical, surgical and genetics care. Our team includes physicians, nurses, advanced practice providers, genetic counselors, exercise physiologists and scientists.

    Dr. Parikh's own clinical practice and laboratory are focused on the genetics of cardiomyopathies and their associated arrhythmogenic substrates. She completed clinical cardiology fellowship at Stanford School of Medicine and her medical residency at the University of California, San Francisco. Funded by multiple research grants from the NIH, her lab seeks to identify novel mechanisms and therapeutic technologies for genetic cardiomyopathy as well as better understand the natural histories of patients affected by these diseases.

  • Walter Park

    Walter Park

    Professor of Medicine (Gastroenterology and Hepatology)

    Current Research and Scholarly InterestsDr. Park's research interests are in the diagnosis and management of pancreatic cysts, acute and chronic pancreatitis. His approach incorporates methods in health services research including the use of observational datasets, cost-effectiveness studies, and the development of clinical cohorts.

  • Jane Parnes

    Jane Parnes

    Professor of Medicine, Emerita

    Current Research and Scholarly InterestsThe lab is studying the mechanisms controlling B cell responsiveness and the balance between tolerance and autoimmunity. B cells deficient in CD72 are hyperresponsive to stimulation through the B cell receptor. We are examining the alterations in B cell signaling in these B cells and the mechanisms by which CD72 deficiency partially abrogates anergic tolerance. We hope to learn how deficiency in CD72 leads to spontaneous autoimmunity and increased susceptibility to induced autoimmune disease.

  • Julie Parsonnet

    Julie Parsonnet

    George DeForest Barnett Professor of Medicine, Emerita

    Current Research and Scholarly InterestsI am an infectious diseases epidemiologist who has done large field studies in both the US and developing countries. We research the long-term consequences of chronic interactions between the human host and the microbial world. My lab has done fundamental work establishing the role of H. pylori in causing disease and understanding its epidemiology. Currently, our research dissects how and when children first encounter microbes and the long term effects of these exposures on health.

  • Gopanandan Parthasarathy

    Gopanandan Parthasarathy

    Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology

    BioDr Nandan Parthasarathy is a hepatologist and physician-scientist in the Department of Gastroenterology and Hepatology at Stanford University.
    After obtaining his medical degree in JIPMER, India, he completed a 2 year clinical research fellowship at Mayo Clinic, following which he completed his residency training at Cleveland Clinic, and GI and transplant hepatology fellowships at Mayo Clinic. During his fellowship, his research work was focused on exploring the immune mechanisms of liver injury in metabolic dysfunction associated steatohepatitis.
    Clinically, he is focused on taking care of patients with MASH, cirrhosis and liver cancer.
    His career goal is to study the gut-immune system-liver injury axis in order to bring novel therapeutics from the bench to bedside in patients with liver disease.

  • Michele Lanpher Patel

    Michele Lanpher Patel

    Instructor, Medicine - Stanford Prevention Research Center

    BioMichele L. Patel, PhD is an Instructor in the Stanford Prevention Research Center at the Stanford University School of Medicine. Trained as a clinical health psychologist, Dr. Patel conducts research to optimize scalable digital health interventions for adults with obesity. She leads clinical trials that test innovative strategies to address the critical challenge of suboptimal engagement in digital interventions.

    Dr. Patel's research is supported by an NIH career development award (K23; 2022-2027). Her recent Spark trial investigated the most potent combination of self-monitoring strategies in a behavioral weight loss intervention among 176 adults with overweight or obesity. Results are expected to be published in 2026.

    She is also testing other strategies to promote engagement, weight loss, and health. This includes the impact of easier vs. harder goals, and the effect of high-frequency, low-friction behavioral strategies. Her work leverages the Multiphase Optimization Strategy (MOST) to systematically identify intervention strategies that maximize effectiveness while minimizing patient burden.

    Dr. Patel received her PhD in clinical psychology from Duke University. She completed her clinical internship at the VA Palo Alto with a specialization in behavioral medicine, followed by a postdoctoral fellowship (T32) at the Stanford Prevention Research Center. She currently serves as the Chair of the Optimization of Behavioral and Biobehavioral Interventions special interest group in the Society of Behavioral Medicine.

    Primary Research Interests:
    -- Optimizing digital interventions for obesity treatment and prevention
    -- Leveraging behavioral science to create lower-burden self-monitoring strategies to improve engagement and outcomes
    -- Identifying psychosocial factors (including health literacy and self-efficacy) that influence treatment success

    Methodological Expertise:
    -- Randomized clinical trials, including factorial designs and embedded trials
    -- Systematic reviews
    -- Signal detection analysis

  • Neha Patel, MD

    Neha Patel, MD

    Clinical Assistant Professor, Medicine - Oncology

    BioDr. Neha Patel is a triple board-certified, fellowship-trained medical oncologist with Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Division of Oncology at Stanford University School of Medicine.

    Dr. Patel provides expert, personalized care for patients with both common and rare cancers and specializes in treating patients with genitourinary cancer. She is deeply committed to delivering comprehensive, patient-centered oncology services, with an emphasis on helping individuals and their families understand their diagnosis and navigate treatment options with confidence and clarity.

    Her research focuses on designing and implementing system-level interventions to advance equitable, high-value cancer care. Dr. Patel is particularly passionate about integrating oncology and palliative (symptom-relieving) care—creating collaborative models that improve patient outcomes, elevate the quality of life, and enhance the overall care experience.

    Known for her compassionate and relational approach, Dr. Patel builds strong, trusting partnerships with the patients and families she serves. She prioritizes care that aligns with each individual’s values, preferences, and goals, with the aim of achieving the best possible quality of life and longevity.

  • Achyut Patil, MD

    Achyut Patil, MD

    Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioDr. Achyut Patil is a board-certified pulmonologist at Stanford Health Care and a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy & Critical Care Medicine at Stanford University School of Medicine.

    He diagnoses and treats disorders of the lungs and respiratory system, including pneumonia and chronic obstructive pulmonary disease (COPD). In addition, Dr. Patil performs various pulmonary and critical care procedures. These include bronchoscopy (viewing the airways with a camera scope) and catheterization (placing a thin tube into a blood vessel for monitoring), among others.

    Dr. Patil’s research interests include improving the experience of medical school trainees. He is also involved in teaching resident and fellow physicians.

    Dr. Patil has published in the peer-reviewed journals Neuro Oncology, Journal of Biological Chemistry, and Lipids.

  • Ria Paul

    Ria Paul

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    BioClinical Focus
    .Internal Medicine
    .Geriatric Medicine
    .Wellness
    .Focus on Health Disparities in Elderly Population

  • Mark Pegram

    Mark Pegram

    Susy Yuan-Huey Hung Professor

    Current Research and Scholarly InterestsMolecular mechanisms of targeted therapy resistance in breast and other cancers

  • Marco Perez

    Marco Perez

    Associate Professor of Medicine (Cardiovascular Medicine)

    BioDr. Marco Perez's research goal is to better understand the fundamental causes of cardiovascular disease through the study of genetics and epidemiology. His group studies the genetic variations and environmental exposures that are associated with conditions such as atrial fibrillation and heart failure. He has led the studies of atrial fibrillation in Women's Health Initiative, one of the largest nation-wide population-based cohorts. He is currently conducting a large study monitoring for silent or asymptomatic atrial fibrillation in women from the WHI randomized to exercise intervention, and was co-PI of the Apple Heart Study, a clinical trial that validated the ability of a smartwatch to detect atrial fibrillation. He is now PI of the Clinical Coordinating Center at Stanford for the REACT-AF which is a clinical trial to evaluate efficacy and safety of a "pill-in-the pocket" approach to anticoagulation for AF using a smartwatch. He is interested in understanding the paradox that atrial fibrillation is less common in African Americans and Hispanics, despite a greater burden of risk factors such as hypertension. As director of the Stanford Inherited Arrhythmia Clinic, he evaluates families with rare inherited arrhythmias associated with sudden death such as Long QT and Brugada Syndromes and explores their links with novel genes. He also studies the genetic causes of very early onset atrial fibrillation. He also studies how best to use the electrocardiogram and imaging modalities using Machine Learning techniques to identify patients at risk for cardiovascular disease. Dr. Perez receives funding from the NIH/NHLBI, Apple Inc., Janssen and the Colson Foundation.

  • Alexander C. Perino

    Alexander C. Perino

    Clinical Associate Professor, Medicine - Cardiovascular Medicine

    BioAlexander C. Perino, MD is a cardiac electrophysiologist at Stanford Health Care whose primary focus is providing procedural care for patients with heart rhythm disorders. He performs a wide range of ablation and cardiac device implantation procedures, utilizing cutting-edge techniques and technologies to deliver high-quality, patient-centered care.

    Dr. Perino serves as the Director of the Electrophysiology Laboratory at Stanford Health Care, where he leads efforts to enhance procedural quality, safety, and patient outcomes across the electrophysiology program. He is also the principal investigator for numerous clinical trials, working to ensure that patients have the opportunity to participate in research and contribute to scientific advancement—without compromising the quality of their care.

    In addition, Dr. Perino is the Medical Informatics Director for the Division of Cardiovascular Medicine at Stanford Health Care. In this role, he oversees initiatives aimed at improving the quality and safety of cardiovascular care, while optimizing the electronic health record to better support patients and clinicians alike.

  • VJ Periyakoil, Professor of Medicine

    VJ Periyakoil, Professor of Medicine

    Professor of Medicine (Primary Care and Population Health)

    Current Research and Scholarly InterestsMy lab is focused on longevity and healthy aging research.

  • Jeffrey Petersen

    Jeffrey Petersen

    Professor of Medicine (Nephrology) at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly InterestsHigh flux dialysis in in-vivo and in-vitro clearances, of small and middle molecular weight solutes; computerized capture, of interdialysis hemodynamics; biocompatibility of biomembranes;, dialysis-related amyloidosis

  • Michael Adam Pfeffer

    Michael Adam Pfeffer

    Chief Information Officer, Stanford Health Care and Stanford School of Medicine, Associate Dean, Stanford School of Medicine, and Clinical Professor, Medicine
    Clinical Professor, Medicine

    BioMichael A. Pfeffer, MD, FACP serves as Chief Information Officer and Associate Dean for Stanford Health Care and Stanford University School of Medicine. Michael oversees Technology and Digital Solutions (TDS), responsible for providing world class technology solutions to Stanford Health Care and School of Medicine, enabling new opportunities for groundbreaking research, teaching, and compassionate care across two hospitals and over 150 clinics. TDS supports Stanford Medicine’s mission to improve human health through discovery and care and strategic priorities to be value focused, digitally driven, and uniquely Stanford.

    Michael is a Clinical Professor in the Department of Medicine and Division of Hospital Medicine with a joint appointment in the center for Biomedical Research (BMIR) in Stanford University School of Medicine. As such, Michael continues to provide clinical care as a Hospitalist Physician as well as teaching medical students and residents on the medicine inpatient wards.

    Prior to joining Stanford Medicine, Michael served as the Assistant Vice Chancellor and Chief Information Officer for UCLA Health Sciences. During his tenure, Michael served as the lead physician for the largest electronic health record “big bang” go-live of its time, encompassing over 26,000 users. Michael subsequently became the first Chief Medical Informatics Officer for UCLA Health before transitioning into the Chief Information Officer position. Under his leadership, UCLA Health IT achieved numerous industry awards including the HIMSS Analytics Stage 7 Inpatient, Ambulatory, and Analytics Certifications; the Most Wired designation for eight consecutive years; US News & World Report’s Most Connected Hospitals; the Top Master’s in Healthcare Administration 30 Most Technologically Advanced Hospitals in the World; and the prestigious HIMSS Davies Award. Michael also implemented of one of the first ACGME-accredited Clinical Informatics Fellowship Programs and served as its Associate Program Director.

    Michael has lectured worldwide on health information technology; served on the national HIMSS Physician Committee and as a HIMSS Stage 7 international site surveyor; and has published numerous peer-reviewed articles on health IT. Michael was featured in Becker’s Hospital Review as 10 physician CIOs to know and 12 standout healthcare CIOs and was one of LA’s top doctors in Los Angeles Magazine.

  • Anuradha Phadke

    Anuradha Phadke

    Clinical Associate Professor, Medicine - Primary Care and Population Health

    BioDr. Phadke is a board-certified primary care internal medicine physician and Clinical Associate Professor of Primary Care & Population Health at the Stanford School of Medicine. She holds several administrative roles including Associate Physician Improvement Leader for the Stanford Department of Medicine, Associate Chief Quality Officer for Ambulatory Care and Population Health at Stanford Healthcare, and co-chair of the Quality Improvement Subcommittee for the Society for General Internal Medicine.

    In her clinical care, she enjoys forming deep and lasting relationships with patients. She seeks to listen actively and provide patients with guidance and support as they work toward their health goals. Her clinical expertise is in chronic disease management and preventive care.

    She teaches clinical primary care to internal medicine residents and medical students. She actively mentors student and resident quality improvement projects.

    Her scholarly focus is ambulatory quality improvement evaluation. She has published and presented on a wide array of topics including workforce QI engagement, quality improvement evaluation of primary care improvement initiatives, hypertension management, and quality improvement to narrow health disparities. She enjoys working with trainees and students on scholarship.

  • Edward A. Pham

    Edward A. Pham

    Instructor, Medicine - Gastroenterology & Hepatology

    BioMy interest in medicine and research was triggered by my mother’s battle with chronic hepatitis C, which made me realize the transformational power of biomedical research in treating patients. Therefore, my career goal is to become a physician scientist in the field of gastroenterology and hepatology dedicated to translating discoveries in the laboratory into novel medical treatment modalities. My research focus is alterations in phosphoinositides signaling and its pathogenesis in cancers of the hepatobiliary and luminal GI tract with the goal to identify novel targets for therapeutic intervention. I also have a particular interest in understanding the interface between chronic viral infection and cancer through studying how the innate and adaptive immune system are perturbed in chronic viral infections

  • Rachyl Leonor Pines

    Rachyl Leonor Pines

    Instructor, Medicine - Primary Care and Population Health

    BioRachyl Pines PhD, focuses on improving the patient experience and increasing provider professional fulfillment through coaching, consults, and communication trainings. Rachyl conducts and oversees research and evaluation to add to the body of knowledge on relationship-centered care and communication in healthcare.
    Prior to joining Stanford, Rachyl was a Research Scientist at Cottage Health Research Institute at Santa Barbara Cottage Hospital where she supported pediatric, behavioral health, population health, women’s services and RN-led research at the hospital. Her other experience includes a brief postdoctoral fellowship with the Terasaki Institute for Biomedical Innovation and UCLA, focused on patient education and equity in renal replacement therapies and a Visiting Researcher position with Tufts University School of Medicine. She also serves as an executive officer for the International Association of Language and Social Psychology.
    She received her MA and PhD in Communication from University of California, Santa Barbara with a focus in health communication. Her dissertation focused on training healthcare staff to better communicate with aggressive patients to prevent workplace violence. In addition, Rachyl has received grant-funding for international projects about intercultural differences in patient preferences for decision-making power with their providers.